chr20-62656704-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016354.4(SLCO4A1):c.250G>A(p.Val84Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000155 in 1,610,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016354.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLCO4A1 | NM_016354.4 | c.250G>A | p.Val84Met | missense_variant | 2/12 | ENST00000217159.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLCO4A1 | ENST00000217159.6 | c.250G>A | p.Val84Met | missense_variant | 2/12 | 1 | NM_016354.4 | P1 | |
SLCO4A1 | ENST00000370507.5 | c.250G>A | p.Val84Met | missense_variant | 1/11 | 1 | P1 | ||
SLCO4A1 | ENST00000497209.5 | c.250G>A | p.Val84Met | missense_variant, NMD_transcript_variant | 2/10 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152264Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000250 AC: 6AN: 240320Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131512
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1457880Hom.: 0 Cov.: 36 AF XY: 0.0000166 AC XY: 12AN XY: 725036
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152264Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74386
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.250G>A (p.V84M) alteration is located in exon 2 (coding exon 1) of the SLCO4A1 gene. This alteration results from a G to A substitution at nucleotide position 250, causing the valine (V) at amino acid position 84 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at